Afro-Latinos Have A Conversation On Blackness
The Sherman Antitrust Act of 1890 was the first measure passed by the U.S. Congress to prohibit abusive monopolies, and in some ways it remains the most important.
|

The ground beef—much of it grass-fed—was sold under the Marketside Butcher and Thomas Farms brands and shipped to Walmart and other retailers nationwide. All items were produced on June 1, 2020 and include the establishment number EST. 46841 in the USDA mark of inspection. The meat has use or freeze by dates of 6/25/20, 6/27/20, or 7/01/20, depending on the specific package size and brand.
These are the specific items subject to recall—you can find images of their packaging here.
Risk Statement: Substantial methanol exposure “could result in nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma, permanent damage to the nervous system or death. Although all persons using these products on their hands are at risk, young children who accidentally ingest these products and adolescents and adults who drink these products as an alcohol (ethanol) substitute, are most at risk for methanol poisoning.”
To date, Saniderm has not received any reports of adverse events related to the product in question.
The product is a hand sanitizer and is packaged in 1-liter plastic bottles with an orange twist-top cap. The affected Sandiderm Advanced Hand Sanitizer include lot number 53131626, manufactured date April/1/20, clear bottle that can be further distinguished by looking at the back side label and identifying “Made in Mexico” and “Produced by: Eskbiochem SA de CV”. No other bottles distributed by Saniderm match the description above, hence all products as described above are subject to the voluntary recall. The product can be identified by the photos below. The product was distributed in Virginia, Maryland, and New Jersey on April 15,2020.
Saniderm is notifying its distributors and customers by email and is arranging for the handling of all voluntary recalled products. All individuals that have the bottle in question should immediately stop using and contact Saniderm for guidance on the return and disposal of the product.
Consumers with questions regarding this voluntary recall can contact Saniderm at +1 (415) 562-5502 or info@sanidermproducts.com from Monday-Friday 9am-6pm, PST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this drug product.
The Fresh Express recall includes only those salads that are clearly marked with the letter Z at the beginning of the Product Code, which is located in the upper right-hand corner of the front of the package. Products containing the ingredients iceberg lettuce, red cabbage and/or carrots AND displaying the Product Code Z178, or a lower number, are recalled.
Recalled products were distributed to select retail stores between June 6 and June 26 in various states including, for example, Arkansas, Connecticut, Delaware, Iowa, Illinois, Indiana, Kansas, Kentucky, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Montana, North Carolina, North Dakota, Nebraska, New Jersey, New York, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Dakota, Tennessee, Virginia, Vermont, Wisconsin, West Virginia, and the District of Columbia.
No other Fresh Express products are subject to recall.
Fresh Express customers have been notified of the recall and instructed to immediately remove recalled products from all store shelves, distribution, and other inventories to ensure they are no longer available for sale or consumption.
Consumers who may have a recalled salad should discard it immediately and not eat it. Consumers with questions, or to obtain refunds, may contact the Fresh Express Consumer Response Center toll-free at (800) 242-5472 on Monday through Saturday from 8 a.m. to 7 p.m. Eastern time and on Sunday from 11 a.m. to 7 p.m. Eastern time.
The product is used as a hand sanitizer and is packaged in 1-liter plastic bottles. The affected SANIDERM ADVANCED HAND SANITIZER includes lot number 0530, Expiration date 04/2022. The product can be identified by the label below. Product was distributed Nationwide in the United States.
UVT, INC. is notifying its distributors and customers by phone calls, emails and letter and is arranging for replacement and destruction of all recalled products.
Consumers/distributors/retailers that have product which is being recalled should stop using products, initiate recalls to the user level, and return all products to the place of purchase. purchase.
Consumers with questions regarding this recall can contact UVT, INC. by phone (951) 427- 3108 or e-mail to customerservice@uvt.world Monday to Friday from 9:00 am and 3:00 pm Pacific Time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Hy-Vee, Inc., based in West Des Moines, Iowa, is recalling an additional 12 salads across its eight-state region due to the potential that they may be contaminated with Cyclospora. The potential for contamination was brought to Hy-Vee’s attention when Fresh Express – which manufactures the product – announced that the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control Prevention (CDC) expanded its investigation of an outbreak of Cyclospora in the upper Midwest section of the United States. The 12 salads are in addition to the 12 oz. Hy-Vee Bagged Garden Salad product that Hy-Vee pulled last week after initial notification of the investigation. Hy-Vee now has 13 private label bagged salad products (all expiration dates) that are being recalled as a result.
The products were distributed to Hy-Vee grocery stores across its eight-state region of Iowa, Illinois, Missouri, Kansas, Nebraska, South Dakota, Minnesota and Wisconsin.
The list below outlines the 13 products that have been recalled. No other Hy-Vee branded salads are impacted by today’s recall.
| UPC | DESCRIPTION | SIZE |
| 0-07450-24669 | HY-VEE SOUTHWEST CHOPPED SALAD KIT | 13.4 OZ |
| 0-07545-12053 | HY-VEE SHREDDED ICEBERG | 8 OZ |
| 0-75450-08530 | HY-VEE VEGGIE DELUXE SALAD | 12 OZ |
| 0-75450-12046 | HY-VEE GREENER SUPREME BLEND | 12 OZ |
| 0-75450-12047 | HY-VEE AMERICAN BLEND SALAD | 12 OZ |
| 0-75450-12048 | HY-VEE ITALIAN BLEND SALAD | 10 OZ |
| 0-75450-12051 | HY-VEE COLESLAW MIX | 16 OZ |
| 0-75450-12058 | HY-VEE ROMAINE GARDEN SALAD | 12 OZ |
| 0-75450-24668 | HY-VEE ASIAN CHOPPED SALAD KIT | 13.7 OZ |
| 0-75450-24670 | HY-VEE SUNFLOWER CHOPPED SALAD KIT | 13.2 OZ |
| 0-75450-24672 | HY-VEE CHIPOTLE CHEDDAR CHOPPED KIT | 11.4 OZ |
| 0-75450-24674 | HY-VEE GARDEN SALAD | 12 OZ |
| 0-75450-24715 | HY-VEE AVOCADO RANCH CHOPPED KIT | 12.8 OZ |
Customers who purchased any of these products should discard them or return them to their local Hy-Vee store for a full refund.
Symptoms of cyclosporiasis begin an average of seven days after ingestion of Cyclospora. Symptoms of cyclosporiasis may include: watery diarrhea (most common), loss of appetite, weight loss, cramping, bloating, increased gas, nausea, fatigue, vomiting, and low-grade fever. If not treated, symptoms can persist for several weeks to a month or more. People who are in poor health or who have weakened immune systems may be at higher risk for severe or prolonged illness.
Consumers with questions may contact Hy-Vee Customer Care representatives 24 hours a day, seven days a week at 1-800-772-4098.
Pilgrim’s Pride Corporation, a Waco, Texas establishment, is recalling approximately 59,800 pounds of fully cooked chicken breast nugget products that may be contaminated with extraneous materials, specifically flexible rubber material, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today.
The frozen ready-to-eat (RTE) chicken breast nugget items were produced on May 6, 2020. The following products are subject to recall [View Labels (PDF Only)] :
The products subject to recall bear establishment number “P-20728” printed on individual retail packages as well as product cases. These items were shipped to retail locations in Arizona, Idaho, Oregon, and Texas.
The problem was discovered after the firm received a consumer complaint reporting rubber pieces in the chicken breast nuggets product.
There have been no confirmed reports of adverse reactions due to consumption of these products. Anyone concerned about an injury or illness should contact a healthcare provider.
FSIS is concerned that some product may be in consumers’ freezers. Consumers who have purchased these products are urged not to consume them. These products should be thrown away or returned to the place of purchase.
FSIS routinely conducts recall effectiveness checks to verify recalling firms notify their customers of the recall and that steps are taken to make certain that the product is no longer available to consumers.
Consumers with questions about the recall can contact Ed Tyrrell, Consumer Relations Manager for Pilgrim’s Pride Corporation, at (800) 321-1470. Members of the media with questions about the recall can contact Nikki Richardson, Director of Communications for Pilgrim’s Pride Corporation, at (970) 506-8028.
The company said that customers should dispose of the salad immediately or return them to the store for a full refund.
The salad mixes were sold in Iowa, Illinois, Missouri, Kansas, Nebraska, South Dakota, Minnesota, and Wisconsin.
These lots were distributed nationwide between February 5, 2020 and June 3, 2020 within the United States. GSK Consumer Healthcare has notified wholesalers, distributors and retailers to arrange for return of any recalled product. Wholesalers, distributors and retailers with an existing inventory of the lots being recalled should stop distribution and quarantine these lots immediately. Wholesalers, distributors and retailers that have further distributed the recalled product should notify any accounts or additional locations which may have received the recalled product from them.
Consumers with questions regarding this recall or to report an adverse experience please call 1-800-762-4675, Monday – Friday, 8:00am – 6:00pm EST.
The products subject to recall bear establishment number “EST. 46841” inside the USDA mark of inspection. These items were shipped to retail locations nationwide.
The problem was discovered during routine FSIS testing. There have been no confirmed reports of adverse reactions due to consumption of these products.
Anyone concerned about an injury or illness should contact a healthcare provider. E. coli O157:H7 is a potentially deadly bacterium that can cause dehydration, bloody diarrhea and abdominal cramps 2–8 days (3–4 days, on average) after exposure the organism. While most people recover within a week, some develop a type of kidney failure called hemolytic uremic syndrome (HUS). This condition can occur among persons of any age but is most common in children under 5-years old and older adults. It is marked by easy bruising, pallor, and decreased urine output. Persons who experience these symptoms should seek emergency medical care immediately.
FSIS is concerned that some product may be in consumers’ refrigerators or freezers. Consumers who have purchased these products are urged not to consume them. These products should be thrown away or returned to the place of purchase.
FSIS routinely conducts recall effectiveness checks to verify recalling firms notify their customers of the recall and that steps are taken to make certain that the product is no longer available to consumers. When available, the retail distribution list(s) will be posted on the FSIS website at www.fsis.usda.gov/recalls.
FSIS advises all consumers to safely prepare their raw meat products, including fresh and frozen, and only consume ground beef that has been cooked to a temperature of 160°F. The only way to confirm that ground beef is cooked to a temperature high enough to kill harmful bacteria is to use a food thermometer that measures internal temperature, https://www.fsis.usda.gov/safetempchart.
Consumers and members of the media with questions about the recall can contact the Lakeside Processing Center Call Center at (856) 832-3881.
|
Product Name |
NDC |
Lot Number |
Expiration Date |
|---|---|---|---|
| Metformin Hydrochloride Extended-Release Tablets USP, 500mg | 68180-336-07 | G901203 | 12/2020 |
The product can be identified by the NDC and the lot number available on the side of the bottle label. Metformin Hydrochloride Extended-Release Tablets USP, 500mg was distributed nationwide in the USA to wholesalers, distributors, and mail order pharmacies.
Lupin Pharmaceuticals Inc. is notifying its wholesalers, distributors, and mail order pharmacies by phone and through recall notification and is arranging for the return of all the recalled product lot. Patients taking Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, are advised to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment. According to the U.S. Food & Drug Administration, it could be dangerous for patients with this serious condition to stop taking their metformin without first talking to their health care professionals. Please visit the agency’s website for more information at https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-metformin.
Wholesalers, distributors, and retailers that have Metformin Hydrochloride Extended-Release Tablets USP, 500mg which is being recalled should discontinue distribution of the recalled product lot immediately and return it to Inmar Rx Solutions, Inc., 635 Vine St, Winston Salem, NC 27101. Tel: (855) 532-1856.
Consumers, wholesalers, distributors, and retailers with questions regarding this recall should contact Inmar Rx Solutions, Inc. at (855) 532-1856 Monday – Friday 09:00 am to 05:00 pm EST. For reimbursement, please have the recalled lot returned to Inmar Rx Solutions, Inc.; the lot number can be found on the side of the bottle.
Epinephrine auto-injectors are not being recalled. FDA urges patients to use the epinephrine auto-injector they have on hand and be aware of the potential issues outlined in the statement above.
Health care professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:
Patients who know that they have an Allergan implant, and may not have participated in device tracking previously, or who need to update their information on www.BIOCELLinformation.com. External Link DisclaimerThe website will inform them how to register for device tracking, which is strongly advised for all patients, and answer any questions they may have.
Patients with BIOCELL® implants or tissue expanders or a history of BIOCELL® implants or tissue expanders should go to www.BIOCELLinformation.com External Link Disclaimerto learn about the BIOCELL® recall, symptoms of Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), the importance of breast self-examination and the need for regular breast implant monitoring.
“We are determined to make sure every woman has the information they need related to the BIOCELL® voluntary recall and we will continue to encourage women with breast implants to determine their implant type and opt-in to our device tracking system. Patient education is a priority. We have partnered with the American Society of Plastic Surgeons (ASPS) and the American Society of Aesthetic Plastic Surgery (ASAPS) on major initiatives to raise awareness regarding the importance of breast implant tracking,” said Carrie Strom, Senior Vice President AbbVie and President Global Allergan Aesthetics.
About the GLOBAL BIOCELL® Recall
On July 24, 2019 Allergan initiated a voluntary global recall of its BIOCELL® breast implants and tissue expanders. Allergan has continued a global basis to ensure that patients and health care professions are notified about the BIOCELL® recall. The Company issued global press releases and distributed letters directly to healthcare professionals regarding the recall. To generate awareness and provide
a resource for patients, the Company launched a dedicated website, http://www.BI- OCELLinformation.com, to help patients identify their breast implants and to provide information and resources related to the risk of BIA-ALCL.
Allergan Aesthetics, an AbbVie company will continue to work closely with global regulatory authorities and societies and patient advocacy groups to provide important BIOCELL® information to patients and health care professionals regarding the voluntary recall.
For more information on the BIOCELL® recall, please click here for the press release.
More information on BIA-ALCL
BIA-ALCL is not breast cancer—it is a type of non-Hodgkin’s lymphoma (cancer of the immune system). At this time, the likelihood of developing BIA-ALCL is thought to be low, occurring in less than 0.03% of patients with
BIOCELL® textured breast implants. However, BIA-ALCL is a serious condition and
can lead to death, especially if not diagnosed early or treated promptly.
About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.AllerganAesthetics.com.
The StealthStation DBS Software with the NexFrame Stereotactic System and O-arm Imaging System provides images of a patient’s brain to help surgeons navigate surgical tools and implants used during a deep brain stimulation (DBS) procedure.
Medtronic has recalled the auto-registration feature of the StealthStation DBS Software due to inaccuracies caused by minor patient movements during the auto-registration process when used with NexFrame during a DBS procedure, which may not be detected by the surgeon or the device system. This may provide inaccurate registration data which could lead surgeons to inaccurately navigate lead placement during image guided DBS procedures. This could result in serious or life-threatening patient harm.
As of June 2020, a total of 33 medical device reports were identified: 22 related to device malfunction and 11 related to injuries
On August 9, 2019, Medtronic sent Urgent Medical Device Correction letters to all affected customers. The letter advised physicians to weigh the benefits vs. risks of fiducial-based or fiducial-less registration methods and provided the following instructions:
Following the O-arm auto-registration step, but prior to using the StealthStation DBS Software with the NexFrame Stereotactic System and O-arm Imaging System for intraoperative navigation:
Medtronic has also added instructions to the label on how to use the device and software. In addition, Medtronic has an updated training program to inform physicians of the inaccuracies due to undetected patient motion that resulted in this recall. FDA is continuing to work with Medtronic to determine whether additional mitigations may be needed.
Health care professionals and distributors with questions about this recall should contact Medtronic and call 1-888-826-5603 or email rs.navtechsupport@medtronic.com.
You must be logged in to post a comment.